SAP reports strong Q2 financial results driven by cloud growth

Dominik Asam Chief Financial Officer SAP SE
Dominik Asam Chief Financial Officer - SAP SE
0Comments

SAP SE reported its financial results for the second quarter and half-year of 2025. The company highlighted a current cloud backlog of €18.1 billion, marking an increase of 22% or 28% at constant currencies. Cloud revenue rose by 24%, with an increase to 28% at constant currencies, while the Cloud ERP Suite revenue saw a growth of 30%, reaching up to 34% at constant currencies. Total revenue increased by 9%, with a rise to 12% at constant currencies.

The IFRS operating profit was reported at €2.5 billion, while the non-IFRS operating profit reached €2.6 billion, showing an increase of 32% and up to 35% at constant currencies. The outlook for the year remains unchanged.

Christian Klein, CEO of SAP SE, stated: “We have delivered yet another quarter of outstanding results. AI innovations such as Joule becoming available ‘everywhere and for everything’ and SAP Business Data Cloud as a powerful accelerator of AI make our portfolio ever stronger. Enterprise operations are about to enter a new era, and SAP is best positioned to benefit from that evolution.”

Dominik Asam, CFO of SAP SE, commented: “We achieved a very good Q2, with accelerating total revenue growth, strong profitability and free cash flow. Our performance was supported by continued customer demand and disciplined cost control. As we move into the second half, we remain cautiously optimistic, keeping a close eye on geopolitical developments and public sector trends.”

For press inquiries only: Joellen Perry can be contacted at +1 (650) 445-6780 or via email at [email protected] during PT hours; Daniel Reinhardt is available at +49 (6227) 7-40201 or [email protected] during CET hours.

For financial community inquiries only: Alexandra Steiger can be reached at +49 (6227) 7-60437 or [email protected] during CET hours.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.